Role of oxidation polymorphism on blood and urine concentrations of amitriptyline and its metabolites in man
- PMID: 7159207
- DOI: 10.1007/BF02141782
Role of oxidation polymorphism on blood and urine concentrations of amitriptyline and its metabolites in man
Abstract
We have measured the metabolites (demethylated and hydroxylated) of amitriptyline in a group of seven normal volunteers. They were phenotyped as extensive or poor metabolizers using debrisoquine and bufuralol. The results demonstrate that the oxidative metabolism (aliphatic hydroxylation) of amitriptyline is under the same genetic control as that of debrisoquine and bufuralol. However, phenotypic polymorphism cannot be used to predict amitriptyline blood concentration after a single oral dose, since the principal metabolic pathway of amitriptyline is demethylation and not aliphatic hydroxylation.
Similar articles
-
[Relationship between amitriptyline metabolism and polymorphic debrisoquine hydroxylation in native Chinese volunteers].Yao Xue Xue Bao. 1993;28(2):85-91. Yao Xue Xue Bao. 1993. PMID: 8328289 Chinese.
-
Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoin.Int Clin Psychopharmacol. 1986 Apr;1(2):102-12. doi: 10.1097/00004850-198604000-00002. Int Clin Psychopharmacol. 1986. PMID: 3571939
-
Elimination and pharmacological effects following single oral doses of 50 and 75 mg of amitriptyline in man.Arch Psychiatr Nervenkr (1970). 1983;233(6):449-55. doi: 10.1007/BF00342785. Arch Psychiatr Nervenkr (1970). 1983. PMID: 6667101
-
The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man.Drug Metab Rev. 2004 Oct;36(3-4):723-46. doi: 10.1081/dmr-200033482. Drug Metab Rev. 2004. PMID: 15554244 Review.
-
Slow hydroxylation of tricyclic antidepressants--relationship to polymorphic drug oxidation.Prog Clin Biol Res. 1986;214:169-88. Prog Clin Biol Res. 1986. PMID: 3523507 Review.
Cited by
-
Clinical pharmacokinetic considerations in the elderly. An update.Clin Pharmacokinet. 1989 Oct;17(4):236-63. doi: 10.2165/00003088-198917040-00003. Clin Pharmacokinet. 1989. PMID: 2686883 Review.
-
Metabolism of amineptine in rat, dog and man.Eur J Drug Metab Pharmacokinet. 1990 Oct-Dec;15(4):339-45. doi: 10.1007/BF03190224. Eur J Drug Metab Pharmacokinet. 1990. PMID: 2088771
-
Steady-state plasma levels of clomipramine and its metabolites: impact of the sparteine/debrisoquine oxidation polymorphism. Danish University Antidepressant Group.Eur J Clin Pharmacol. 1992;43(4):405-11. doi: 10.1007/BF02220617. Eur J Clin Pharmacol. 1992. PMID: 1451721 Clinical Trial.
-
Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals.J Pharmacokinet Pharmacodyn. 2018 Oct;45(5):663-677. doi: 10.1007/s10928-018-9597-6. Epub 2018 Jun 25. J Pharmacokinet Pharmacodyn. 2018. PMID: 29943290 Free PMC article.
-
Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects.Eur J Clin Pharmacol. 2018 Mar;74(3):285-296. doi: 10.1007/s00228-017-2375-3. Epub 2017 Nov 27. Eur J Clin Pharmacol. 2018. PMID: 29181698
References
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases